Forecast

There is no analyst data available for this company.

News Go to news feed

Rakovina Therapeutics closes second private placement tranche of $597,000

Rakovina Therapeutics sold 5,970,000 units at $0.10 each, raising $597,000 in the second and final tranche of a broker-free private placement. Across both tranches the company raised $1,991,000 gross; each unit consists of a common share and a half warrant, with a whole warrant exercisable within 24 months at $0.20. Insiders subscribed for a total of 2,120,000 units; the issued securities are subject to a hold period of four months and one day. The proceeds are intended primarily to advance the pipeline, notably kt-5000AI (ATR/mTOR program), kt-3000 LNP formulation, kt-2000AI and AI-driven lead-structure optimization using Variational AI; the closing is subject to final approval by the TSX Venture Exchange. » More on de.investing.com